These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 7553649)

  • 41. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes.
    Seki T; Miyasu T; Noguchi T; Hamasaki A; Sasaki R; Ozawa Y; Okukita K; Declerck PJ; Ariga T
    J Cell Physiol; 2001 Oct; 189(1):72-8. PubMed ID: 11573206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential endocytosis of tissue plasminogen activator by serpins PAI-1 and PAI-2 on human peripheral blood monocytes.
    Lee JA; Croucher DR; Ranson M
    Thromb Haemost; 2010 Dec; 104(6):1133-42. PubMed ID: 20838737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potentiating effect of endothelial cells on astrocytic plasminogen activator inhibitor type-1 gene expression in an in vitro model of the blood-brain barrier.
    Hultman K; Björklund U; Hansson E; Jern C
    Neuroscience; 2010 Mar; 166(2):408-15. PubMed ID: 20060032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of losartan on expressions of plasminogen activator and plasminogen activator inhibitor-1 of rat proximal tubular epithelial cells cultured with high glucose].
    Pu LJ; Huang SM; Liu F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):813-5. PubMed ID: 17953365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
    Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
    Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice.
    Hua H; Zhang R; Yu S; Wang H; Zhao Y; Yu S; Li W
    Allergol Immunopathol (Madr); 2011; 39(4):206-11. PubMed ID: 21339035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N; Belin D; Failly-Crépin C; Vassalli JD
    Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression of plasminogen activator system in a rat model of periodontal wound healing.
    Xiao Y; Li H; Bunn C; Bartold PM
    J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
    Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
    Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.
    Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R
    Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA).
    Creighton-Kempsford LJ; Pring JB; Gaffney PJ
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):481-3. PubMed ID: 1420825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies.
    Rondeau E; Mougenot B; Lacave R; Peraldi MN; Kruithof EK; Sraer JD
    Clin Nephrol; 1990 Feb; 33(2):55-60. PubMed ID: 2107050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue- and urokinase-type plasminogen activators and type 1 plasminogen activator inhibitor in melanomas and benign skin pigment neoplasms.
    Gershtein ES; Medvedeva SV; Babkina IV; Kushlinskii NE; Trapeznikov NN
    Bull Exp Biol Med; 2001 Jul; 132(1):670-4. PubMed ID: 11687850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.
    Liu YX; Hu ZY; Liu K; Byrne S; Zou RJ; Ny T; d'Lacey C; Ockleford CD
    Placenta; 1998; 19(2-3):171-80. PubMed ID: 9548184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
    Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasminogen activator in granulocyte-macrophage-CSF transgenic mice.
    Elliott MJ; Faulkner-Jones BE; Stanton H; Hamilton JA; Metcalf D
    J Immunol; 1992 Dec; 149(11):3678-81. PubMed ID: 1431138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
    Grøndahl-Hansen J; Kirkeby LT; Ralfkiaer E; Kristensen P; Lund LR; Danø K
    Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.